Infection of COVID-19
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Age 18-90, gender unlimited; (2) Moderate or severe patients with COVID-19 infection or sequelae during recovery; (3) Agree to sign a written notice before the study begins.
Exclusion criteria
Exclusion criteria: (1) Patients with severe non-infectious pulmonary underlying diseases, including lung tumors, pulmonary edema, atelectasis, pulmonary embolism, pulmonary eosinophilic infiltration and pulmonary vasculitis; (2) patients with biliary tract and intestinal obstruction; (3) Pregnant women (urine or serum pregnancy test positive) or lactating women; (4) Patients with decoction intolerance were deemed unsuitable for inclusion in this study by other investigators, or there were any conditions that the investigators considered might increase the risk of the subjects or interfere with the clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of days for nucleic acid test results to turn negative (infected patients);Improvement of clinical symptoms;Quality of life;Clinical test index - oxygen saturation before and after treatment;Clinical examination indicators - heart rate;Clinical laboratory examination index - respiratory rate;Clinical examination indicators - liver and kidney function;Clinical examination indicators - blood routine+CRP;Clinical laboratory examination indicators - CT imaging; | — |
Countries
China
Contacts
South China Hospital of Shenzhen University